AI assistant
TG THERAPEUTICS, INC. — Director's Dealing 2024
Jan 5, 2024
31066_dirs_2024-01-05_b0b1cb57-3a26-43dd-ad95-30e740d630c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2024-01-03
Reporting Person: Power Sean A (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-03 | Common Stock | S | 47867 | $16.91 | Disposed | 606969 | Direct |
| 2024-01-05 | Common Stock | A | 75000 | — | Acquired | 681969 | Direct |
Footnotes
F1: In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F2: Includes shares of restricted Common Stock, which vest over various time periods.
F3: Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028.